ONCONETIX INC
NASDAQ: ONCO (Onconetix, Inc.)
Kemas kini terakhir: 1 jam lalu1.06
-0.79 (-42.70%)
| Penutupan Terdahulu | 1.85 |
| Buka | 1.25 |
| Jumlah Dagangan | 5,864,301 |
| Purata Dagangan (3B) | 84,252 |
| Modal Pasaran | 1,648,316 |
| Harga / Pendapatan (P/E TTM) | 0.001 |
| Harga / Jualan (P/S) | 0.700 |
| Harga / Buku (P/B) | 0.690 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 27 Aug 2025 - 31 Aug 2025 |
| Margin Operasi (TTM) | -1,626.32% |
| EPS Cair (TTM) | -161.50 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -85.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 200.26% |
| Nisbah Semasa (MRQ) | 0.170 |
| Aliran Tunai Operasi (OCF TTM) | -7.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.13 M |
| Pulangan Atas Aset (ROA TTM) | -8.25% |
| Pulangan Atas Ekuiti (ROE TTM) | -201.34% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Onconetix, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.13 |
|
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 57.97% |
| % Dimiliki oleh Institusi | 0.82% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Pacific Capital Wealth Advisors, Inc. | 31 Dec 2025 | 0 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |